ACTIPH is a company that manufactures high-alkaline, ionised water having a 'Power of Hydrogen' (pH) of 9.8 providing the required hydration to people who live an active lifestyle. The company's UK listings include Tesco, Ocado, Harrods, Sainsbury's, Selfridges, Planet Organic, and Wholefoods among others. It also exports to 11 countries globally. By April 2020, the company sold over 1.35 million units and amassed 26,300 social media followers. Alkaline water has become one of the fastest-growing categories globally with sales of $883 million+ in 2018. By 2023, the market is expected to exceed $4.3 billion. ACTIPH aims to be a leading contender in this segment. Its vision is to lead the growth of alkaline waters across Europe and the Middle East. It will use the investment to increase its sales to drive further distribution across Europe, invest in marketing to drive penetration and educate on the health benefits of its products, increase production capability, and accelerate new product development.
days to go:
Expired
investment:
£1,200,004
Patch is a modern plant shop for contemporary plant people. It helps in finding the most suitable plants and delivering them to the door. The company has delivered over 2,50,000 plants to over 82,000 customers in Paris and London. Patch has witnessed solid growth at +124% vs last year, reaching £4.48m in revenue. The company has a 4.6-star rating on TrustPilot and, it has been featured in The Times, The Telegraph etc. The funds will be used to expand across Europe, eliminate the middle-man and expand into the B2B market.
days to go:
Expired
investment:
£2,412,150
Wedding Planner is an online wedding-planning marketplace that provides an easy way to plan and book a wedding. Around 20,000 couples are using this platform to plan their dream weddings. Besides being a pre-COVID profitable business in the UK, it is the UK's number one ranked site for 'Wedding Planner' as per Google. The website has been created by combining a digital wedding booking system, curated venues, planning tools, and supplier search options. The platform generates 8,500+ leads for venues and suppliers per quarter and has a registered base of 3,000+ venues and other suppliers. With the investment, the company will use 25% to update their booking system catering to couples and suppliers, 12% in creating new and tested standardised contract templates between the couple and the supplier, 13% in developing a partnership with a wedding insurance provider, 30% as substitution funds for supplier and venue subscriptions frozen during COVID-19, 13% in continuing the platform's growth in Sweden, and 7% in costs associated with fund-raising.
days to go:
Expired
investment:
£25,010
Actve is on a mission to build a platform that caters to the new wave of instructors, social media influencers and athletes becoming online content creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go:
Expired
investment:
£166,670
Alter Vego (AV) aims to create an extensive range of plant-based, customisable supplements. The company asserts that its production process is sustainable. It starts by creating a vegan protein base blend from ingredients such as pea, hemp, quinoa and brown rice that is ethically sourced and produced. It then develops daily sachets that contain Omega 3, B12, D3, K1, digestive enzymes, and probiotics to complement the base blend. AV argues that the sachets provide 100% of a user's Recommended Dietary Allowance (RDA) over any pre-mixed bulk blend. It aspires to become a contender in the global nutrition sector worth $702 billion. AV will use the investment for manufacturing and marketing its products across the UK.
days to go:
Expired
investment:
£46,455
Future You Cambridge is a company that sells clinically proven health supplements directly to consumers. Since its launch in 2016, it has sold products to over 100,000 customers. The company's Lactolycopene product received a patent in December 2017 and its Fertility+ product was also covered by the European Journal of Nutrition in a clinical paper and was shown to have resulted in a 40% increase in male fertility. The company's offerings now stand at 24 products, including the popular CBD product and its first product for pets, Curcupet-K9. Additionally, the company won the 2018 Cambridge Service Excellence and Independent High Growth Business of the Year Awards and has 5-star ratings on Trustpilot. They will use the investment to scale up direct advertising campaigns, expand its product range by more than 10 new products, and invest in their website to make it more intuitive.
days to go:
Expired
investment:
£655,011
QFinds is a purpose-built hiring tool that enables employers to easily and efficiently pre-screen candidates, conduct interviews and generate employment contracts. The company asserts that it is a UK government vetted 'Kickstart Scheme' representative and can get small businesses grants to hire interns having already processed over 100 job applications. QFinds claims that its app has been downloaded 2 million+ times garnering 24,000 reviews averaging 4.8/5 stars. QFinds also points out that bad hirings cost the UK up to £6.7 billion in turnover, productivity, and training. It seeks to change this and disrupt the £39 billion recruitment market. The company has partnered with notable entities like University College London, Kings College London and Brunel University London, intending to use them as strategic partners to increase job seekers signing up to and using its app. QFinds will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£222,866
Sweat IT is a fitness studio in London, which provides supreme high-intensity training experience with the hardest workouts. The UK fitness industry continues to grow high at a value of over £5 billion because of increasing demand for a healthy lifestyle. Sweat IT redefines this with healthy eating and exercise. The company has the vision to take its business growth to the next level and become the leader of boutique fitness. They have partnered with Gympass, the world’s leading corporate fitness platform to deliver high-intensity fitness classes to London based corporate clients. Till date, they have had over 50,000 class bookings with more than 13,000 Instagram followers and a database of 10,000 customers. The company intends on using the investment for marketing and product branding and next-level growth. They are also looking to fund their second studio in London and have ear-marked a potential site in the City.
days to go:
Expired
investment:
£211,220
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
Rescape is a company pioneering the use of Virtual Reality (VR) in healthcare and frontline services. Its DR.VR platform, launched in 2019, helped reduce pain and anxiety amongst patients in hospitals and care homes. The company delivers VR content to patients through the Samsung Gear VR headset, a hard-plastic headset, that can be wiped down and disinfected along with VR sanitary eye masks that reduce chances of infection and irritation to patients. Through the company's technology, patients can experience ocean life, amusements parks and relax in some of the most beautiful settings in the world, all from the safety of the healthcare institution. The AR/VR in Healthcare Market is predicted to reach USD 30-40 billion by 2026, and Rescape aims to be a disruptor in this segment. The company will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£488,450
